Delivery Order SPE2DB20D3103-SPE2DB25FP5A2

Award Date 7/15/25
Potential Completion Date 7/16/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SYRINGEML. The contract has a ceiling value of $61,017.59 and a period of performance through October 6, 2023. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,080.74 firm fixed-price contract is for the delivery of ENBREL 50 MG/ML syringes, with a period of performance through July 1, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SYRINGEML. The contract has a firm fixed price of $63,147.30 and a completion date of January 21, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,336.81 firm fixed-price contract is for the delivery of ENBREL 50 MG/ML SYRINGEML, a medication. The contract has a performance period ending on July 14, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $16,328.26 and a completion date of May 28, 2025. The contract is a firm fixed-price delivery order and is not a set-aside. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $14,383.25 and a period of performance through June 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $10,800.62 firm fixed-price contract is for the supply of ENBREL 50 MG/ML SYRINGE medication, with a performance period through July 3, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ENBREL 25 MG/0.5 ML syringes, a specialty pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $6,067.06, and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,326.78, is for the delivery of ENBREL 50 MG/ML SYRINGEML, a medication. The contract has an ultimate completion date of June 16, 2025. This is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,059.58, is for the delivery of ENBREL 50 MG/ML SYRINGEML, a specialty pharmaceutical medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP5A2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the supply of ENBREL 50 MG/ML SYRINGE, a pharmaceutical product, with a firm fixed price of $14,479.69 and a period of performance through July 16, 2025. The contract is not set aside and was awarded on an open competitive basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 and positions the company as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 10/14/25, 10:49 AM